Sintx Technologies (SINT) EBT Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186,456.00 |
| Dec 31, 2025 | 72,931.00 |
| Sep 30, 2025 | 199,250.00 |
| Jun 30, 2025 | 43,941.00 |
| Mar 31, 2025 | -118,587.00 |
| Dec 31, 2024 | 8,092.00 |
| Sep 30, 2024 | 5,499.00 |
| Jun 30, 2024 | 18,055.00 |
| Mar 31, 2024 | 155,041.00 |
| Jun 30, 2023 | -37,630.00 |
| Mar 31, 2023 | 9,780.00 |
| Dec 31, 2022 | -43,571.00 |
| Sep 30, 2022 | -58,913.00 |
| Jun 30, 2022 | -99,358.00 |
| Mar 31, 2022 | -218,595.00 |
| Dec 31, 2021 | -126,256.00 |
| Sep 30, 2021 | -82,678.00 |
| Jun 30, 2021 | -205,135.00 |
| Mar 31, 2021 | -252,574.00 |
| Dec 31, 2020 | -144,472.00 |
| Sep 30, 2020 | -348,436.00 |
| Jun 30, 2020 | -185,039.00 |
| Mar 31, 2020 | 67,819.00 |
| Dec 31, 2019 | -20,538.00 |
| Sep 30, 2019 | -75,361.00 |
| Jun 30, 2019 | -21,028.00 |
| Mar 31, 2019 | -159,784.00 |
| Jun 30, 2018 | -5,631.00 |
| Mar 31, 2018 | -8,488.00 |